Further exploration of the downstream mechanism indicated connective tissue growth factor (CTGF) as a potential target molecule of MCM8, knockdown of which could enhance the inhibitory effects of MCM8 silencing, while weakening the promotion effects of MCM8 overexpression on osteosarcoma development. This evidence concerns the gene CCN2 and osteosarcoma.